Prevalence of Obstructive Sleep Apnea and Accuracy of Type 3 Home Sleep Apnea Test for Obstructive Sleep Apnea Diagnosis in Difficult-to-treat Asthma

Last updated: April 1, 2025
Sponsor: Chulalongkorn University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Sleep Apnea Syndromes

Asthma

Treatment

home sleep test

Clinical Study ID

NCT06916858
0722/66
  • Ages 18-80
  • All Genders

Study Summary

cross sectional cohort study enroll Patients diagnosed with difficult-to-treat asthma, aged over 18 years, and experiencing persistent symptoms as assessed by the Asthma Control Test (ACT) underwent type 1 in-laboratory polysomnography and type 3 HSAT within 1 month apart

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • difficult-to-treat asthma .

  • Patients aged 18 years or older

Exclusion

Exclusion Criteria:

  • Patients or volunteers unable to undergo type 1 and type 3 sleep studies,

  • Patients with symptoms compatible with other sleep disorders,

  • Patients with a history of or current stroke or transient ischemic attack and Otherchronic respiratory diseases.

  • Patients diagnosed with obstructive sleep apnea

Study Design

Total Participants: 37
Treatment Group(s): 1
Primary Treatment: home sleep test
Phase:
Study Start date:
February 07, 2024
Estimated Completion Date:
June 30, 2025

Connect with a study center

  • Tidarat Somreusean

    Bangkok,
    Thailand

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.